SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brumar89 who wrote (1368859)7/28/2022 2:42:12 PM
From: Winfastorlose  Read Replies (1) of 1579777
 
That brain dead SOB said the same thing about the vax. Almost verbatim. He was lying then and he is probably lying now. He has a 50 year history of profuse lying.

jennifermargulis.substack.com

What’s the Problem With Paxlovid?

A new study, available as a pre-print (which means it has not yet been peer-reviewed), has found that people who take Paxlovid not only can get re-infected with the virus just a few days after their symptoms clear up, but they are also contagious enough to spread it to other people.

The Centers for Disease Control and Prevention, however, is speaking up. On May 24, the CDC warned that people with COVID-19 who take Paxlovid may experience what they’re calling “a rebound case of COVID” two to eight days after their symptoms initially clear up.

Medical doctors are also reporting seeing a “troubling trend” of COVID-19 reemergence in their patients who have taken Paxlovid. In addition, there are thousands of anecdotal complaints about post-Paxlovid reinfection on social media, as well as in diverse mainstream news outlets, from NPR to NBC.

And now the feds are finally weighing in with this official CDC HEALTH ADVISORY (caps are theirs), which you can read in its entirety in PDF form on-line.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext